Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

Delivering Strategic and Economic Value with MRI-Guided Radiation Therapy

Thu, Jun 24, 2021 · 11:00 AM · EDT
About This Webinar

Join us for this unique opportunity to learn how MRI-guided radiation therapy programs can deliver clinical benefit and how that can translate into strategic and economic value, based on a given center’s practice environment. Hear executive leadership, from two renowned institutions, share their insights into the decision-making factors that led to the investment in MRI-guided radiotherapy. Describing their experience, these executives will share the value MRI-guided radiotherapy brings to their cancer programs. They will discuss the clinical value to their patient care and how this unique technology has changed the types of cancers they treat and how it has added incremental benefits to their overall cancer care.

Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Chair of the Department of Radiation Oncology at Brigham and Women’s
Daphne Haas-Kogan, MD, is Chair of the Department of Radiation Oncology at Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Boston Children’s Hospital. She is the Willem and Corrie Hees Family Professor of Radiation Oncology at Harvard Medical School.
As Department Chair, her vision includes supporting each member of the Radiation Oncology Department in fostering close collaborative ties with diagnostic radiologists, medical and pediatric oncologists, surgeons, pathologists, and basic science investigators to spearhead cutting edge science, translational investigations and clinical studies, all based on the depth and breadth of success that already permeates Dana-Farber/Brigham and Women’s Cancer Center (DFBWCC). Dr. Haas-Kogan is a member of the National Academy of Medicine.
Webinar hosting presenter
Deputy Director, Chief of Radiation Oncology, Miami Cancer Institute
Minesh Mehta, MD, is deputy director and chief of radiation oncology at Miami Cancer Institute, a part of Baptist Health South Florida. He is a widely renowned expert in radiation oncology, proton therapy and cancer research. He has designed and led numerous national and international clinical studies, receiving NIH and NCI grants and winning honors for his research in brain and central nervous system tumors. Dr. Mehta is Board-certified in radiation oncology by the American Board of Radiology and in neuro-oncology by the United Council for Neurologic Subspecialties.
Webinar hosting presenter
Assistant Vice President of Clinical Operations, Radiation Oncology at Miami Cancer Institute
Steven Holan, MBA is the Assistant Vice President of Clinical Operations, Radiation Oncology at Miami Cancer Institute, part of Baptist Health South Florida. Steve’s current role is to oversee clinical operations and to execute the overall strategic goals of the Radiation Oncology Department. He also serves as the executive sponsor for employee engagement and the institute’s diversity, equity, and inclusion initiatives.
Webinar hosting presenter
Executive Director for Radiation Oncology
Mr. Walsh is the Executive Director for Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center, as well as a Teaching Associate at Harvard Medical School. He has held progressive leadership roles DFBWCC over the last 20 years. Mr. Walsh oversaw and directed the growth of the Radiation Oncology Department from four machines to a world-class department with 15 machines and robust Laboratory Research, Physics and Translational Medicine Divisions. In 2007, DFBWCC emphasized expanding Radiation Oncology to the community. Under Mr. Walsh’s leadership, the Radiation Oncology Department developed three network satellites and, more recently, has expanded internationally by bringing radiation oncology services to Bermuda and China. Walsh earned his MBA at Suffolk University and received his BS at Babson College.
Webinar hosting presenter
SVP, Government Affairs & Market Access
Parashar is ViewRay’s Senior Vice President, Government Affairs & Market Access. ViewRay’s MRIdian® Radiation Therapy System makes a difference for cancer patients and their physicians by combining the latest innovations in radiation delivery with ground-breaking magnetic resonance (MR) image guidance and real-time adaptive capabilities.

As a member of the Executive Leadership Team, Parashar shapes the growth trajectory and strategy for the company. He leads global efforts to demonstrate the value of MRIdian and drive adoption of MRIdian in cancer treatment globally. Parashar is responsible for implementing and leading all aspects of government affairs and market access including the strategic vision, plans, and objectives required to both enable and accelerate corporate growth.

Parashar is an experienced health care executive with a demonstrated history of accomplishments in the medical device industry and public sector. His areas of expertise include health care delivery systems, payment and coverage policy, market access, medical devices, and clinical research.

From October 2016 through January 2019 Parashar led Boston Scientific’s Global Health Policy team, which focused on monitoring and influencing payment and health care delivery system policies and shaping Boston Scientific’s commercial strategies in the context of policy trends.
Hosted By
ViewRay webinar platform hosts Delivering Strategic and Economic Value with MRI-Guided Radiation Therapy
ViewRay's webinars
Attended (96) View all
  • 1585169782-8b647e49e11ad11d
  • 1586962146-ecfae0d8b8d7db69
  • 1622046775-ad0fca99af9586bd
  • P
  • S
  • Z
  • 1594752347-66b25d379414b094
  • J
  • 1594752280-51fc8d519dac7d83
  • Y
  • Y
  • D
  • C
  • D
  • R
  • S
  • J
  • M